Drug Profile
LL 10G568-alpha
Latest Information Update: 03 Oct 2011
Price :
$50
*
At a glance
- Originator Wyeth
- Class Antibacterials
- Mechanism of Action Beta lactamase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 20 Feb 1995 Preclinical development for Bacterial infections in USA (Unknown route)